AAAAAA
Results:
1-11
|
Results: 11
Authors:
Kaufman, HL
DeRaffele, G
Divito, J
Horig, H
Lee, D
Panicali, D
Voulo, M
Citation: Hl. Kaufman et al., A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma, HUM GENE TH, 12(11), 2001, pp. 1459-1480
Authors:
Lieberman, SM
Horig, H
Kaufman, HL
Citation: Sm. Lieberman et al., Innovative treatments for pancreatic cancer, SURG CL NA, 81(3), 2001, pp. 715
Authors:
Kicska, GA
Long, L
Horig, H
Fairchild, C
Tyler, PC
Furneaux, RH
Schramm, VL
Kaufman, HL
Citation: Ga. Kicska et al., Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes, P NAS US, 98(8), 2001, pp. 4593-4598
Authors:
Lee, H
Woodman, SE
Engelman, JA
Volonte, D
Galbiati, F
Kaufman, HL
Lublin, DM
Lisanti, MP
Citation: H. Lee et al., Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase - Targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (Tyr-14), J BIOL CHEM, 276(37), 2001, pp. 35150-35158
Authors:
Horig, H
Wainstein, A
Long, L
Kahn, D
Soni, S
Marcus, A
Edelmann, W
Kucherlapati, R
Kaufman, HL
Citation: H. Horig et al., A new mouse model for evaluating the immunotherapy of human colorectal cancer, CANCER RES, 61(23), 2001, pp. 8520-8526
Authors:
Kaufman, HL
Rao, JB
Irivine, KR
Bronte, V
Rosenberg, SA
Restifo, NP
Citation: Hl. Kaufman et al., Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model (vol 22, pg 489, 1999), J IMMUNOTH, 23(4), 2000, pp. 509-509
Authors:
Evans, ME
Jordan, CT
Chang, SMW
Conrad, C
Gerberding, JL
Kaufman, HL
Mayhall, CG
Nolta, JA
Pilaro, AM
Sullivan, S
Weber, DJ
Wivel, NA
Citation: Me. Evans et al., Clinical infection control in gene therapy: A multidisciplinary conference, INFECT CONT, 21(10), 2000, pp. 659-673
Authors:
Horig, H
Lee, DS
Conkright, W
Divito, J
Hasson, H
LaMare, M
Rivera, A
Park, D
Tine, J
Guito, K
Tsang, KWY
Schlom, J
Kaufman, HL
Citation: H. Horig et al., Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule, CANCER IMMU, 49(9), 2000, pp. 504-514
Authors:
Tendler, A
Kaufman, HL
Kadish, AS
Citation: A. Tendler et al., Increased carcinoembryonic antigen expression in cervical intraepithelial neoplasia grade 3 and in cervical squamous cell carcinoma, HUMAN PATH, 31(11), 2000, pp. 1357-1362
Authors:
Kaufman, HL
Rao, JB
Irivine, KR
Bronte, V
Rosenberg, SA
Restifo, NP
Citation: Hl. Kaufman et al., Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model, J IMMUNOTH, 22(6), 1999, pp. 489-496
Authors:
Horig, H
Kaufman, HL
Citation: H. Horig et Hl. Kaufman, Current issues in cancer vaccine development, CLIN IMMUNO, 92(3), 1999, pp. 211-223
Risultati:
1-11
|